The QRS widening by ventricular conventional pacing impairs the systolic and diastolic functions and increases mitral regurgitation. The aim of this study was to compare conventional pacing to an alternative stimulation mode with a narrower QRS using two leads in the RV. Thirty-nine (25 men, 14 women; mean age 60.1 +/- 15.1 years) dilated cardiomyopathy patients (Chagas' disease [n = 17], coronariopathy [n = 9], AV ablation for tachycardiomyopathy [n = 3], and other [n = 10]) with cardiac failure (NYHA 3.1 +/- 0.8), pacemaker indication, and chronic AV block (22 AF) had endocardial pacemaker implantations (27 Biotronik, 12 Guidant). Two RV leads (one septal, one conventional [RV apex] were connected, respectively, to the atrial and ventricular pacemaker plugs. After clinical stabilization they were studied under three stimulation modes in the same session: AAI (septal), VVI (conventional), and ventricular endocardial right bifocal stimulation (VERBS) (DDT/DVI/DDD = AV interval = 15/10 ms). In comparison to conventional pacing, VERBS increased ejection fraction (0.124), cardiac output (19.5%), and peak filling rate (31.0%), and decreased QRS duration (24.7%), left atrium area (11.9%), mitral regurgitation area (32.3%), the diastolic transmitral flow (E/A relation) (19.3%), and the propagation flow time (18.0%) from the mitral valve to the left ventricular apex (tE_col), (P < 0.05). The quality-of-life showed an impressive score reduction of 50.4%. The septal stimulation alone showed a less expressive benefit. In severe dilated cardiomyopathy with classic pacemaker indication, VERBS showed significantly better performance than the septal or the conventional stimulation alone. There was a good systolic and a remarkable diastolic improvement causing an important reduction in the quality-of-life score.
BackgroundHeart failure and atrial fibrillation (AF) often coexist in a deleterious cycle.ObjectiveTo evaluate the clinical and echocardiographic outcomes of patients with ventricular systolic dysfunction and AF treated with radiofrequency (RF) ablation.MethodsPatients with ventricular systolic dysfunction [ejection fraction (EF) <50%] and AF refractory to drug therapy underwent stepwise RF ablation in the same session with pulmonary vein isolation, ablation of AF nests and of residual atrial tachycardia, named "background tachycardia". Clinical (NYHA functional class) and echocardiographic (EF, left atrial diameter) data were compared (McNemar test and t test) before and after ablation.Results31 patients (6 women, 25 men), aged 37 to 77 years (mean, 59.8±10.6), underwent RF ablation. The etiology was mainly idiopathic (19 p, 61%). During a mean follow-up of 20.3±17 months, 24 patients (77%) were in sinus rhythm, 11 (35%) being on amiodarone. Eight patients (26%) underwent more than one procedure (6 underwent 2 procedures, and 2 underwent 3 procedures). Significant NYHA functional class improvement was observed (pre-ablation: 2.23±0.56; postablation: 1.13±0.35; p<0.0001). The echocardiographic outcome also showed significant ventricular function improvement (EF pre: 44.68%±6.02%, post: 59%±13.2%, p=0.0005) and a significant left atrial diameter reduction (pre: 46.61±7.3 mm; post: 43.59±6.6 mm; p=0.026). No major complications occurred.ConclusionOur findings suggest that AF ablation in patients with ventricular systolic dysfunction is a safe and highly effective procedure. Arrhythmia control has a great impact on ventricular function recovery and functional class improvement.
Objective -To describe a new more efficient method of endocardial cardiac stimulation, which produces a narrower QRS without using the coronary sinus or cardiac veins. In dilated cardiomyopathy some degree of delay occurs in myocardial stimulus conduction, which causes QRS widening. Associated lesions in the conduction system also often cause QRS widening. In these cases, when a cardiac pacemaker is necessary, paced QRS is more enlarged, easily achieving 200 ms or even more. The delayed ventricular activation, by itself, provokes systolic and diastolic dysfunction, and increases mitral regurgitation 1 . Since the beginning of cardiac pacing, it has been known that the contraction caused by a paced QRS is less effective than the one resulting from a normal QRS. When the QRS is wide, the increased pressure caused by the first stimulated myocardium area is lessened by the natural complacence of other areas that will be activated later. On the other hand, in the normal contraction, the fast myocardial cell activation creates a mechanical synergism, extremely favorable for taking maximum advantage of the inotropic state. It causes a pressure wave with high dP/dt, which is a faster, highly efficient rise in pressure. In the dilated myocardium, the activation generated by a pacemaker is distributed over a longer time, causing a pressure wave that is more attenuated proportionally to the paced QRS widening. To preserve systolic and diastolic functions, and reduce mitral insufficiency, it appears to be fundamental to pace both ventricles with a normal QRS, or at least with the shortest PRS possible. This can be easily obtained by AAI pacing, when the patient has intra-and atrioventricular conduction systems preserved. In the case of AV block, the resulting ventricular paced QRS (almost always placed on the right ventricle) is very wide. It is possible to have a narrow QRS simultaneously pacing more than one point. Recent studies have shown narrow QRS and improved myocardial contractility, when both ventricles are simultaneously paced 2 . The problem is access to the left ventricle. The first approach was epicardial, which requires a thoracotomy 3 . The alternative is the use of cardiac veins; through the coronary sinus. This method avoids thoracoto- Methods -
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.